Agenus Inc - Asset Resilience Ratio

Latest as of June 2024: 0.73%

Agenus Inc (AGEN) has an Asset Resilience Ratio of 0.73% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Agenus Inc balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$2.14 Million

Cash + Short-term Investments

Total Assets

$292.42 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2023)

This chart shows how Agenus Inc's Asset Resilience Ratio has changed over time. See net assets of Agenus Inc for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Agenus Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see AGEN stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$2.14 Million	0.73%
Total Liquid Assets	$2.14 Million	0.73%

Asset Resilience Insights

Limited Liquidity: Agenus Inc maintains only 0.73% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Agenus Inc Industry Peers by Asset Resilience Ratio

Compare Agenus Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Agenus Inc (2000–2023)

The table below shows the annual Asset Resilience Ratio data for Agenus Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.14%	$447.00K	$313.91 Million	-3.41pp
2022-12-31	3.55%	$14.68 Million	$413.56 Million	+0.33pp
2021-12-31	3.22%	$14.99 Million	$465.96 Million	--
2020-12-31	0.00%	$0.00	$214.51 Million	--
2018-12-31	0.00%	$0.00	$136.40 Million	--
2017-12-31	0.00%	$0.00	$138.40 Million	--
2016-12-31	3.18%	$4.99 Million	$156.99 Million	-11.26pp
2015-12-31	14.43%	$34.96 Million	$242.23 Million	-5.03pp
2014-12-31	19.47%	$14.51 Million	$74.53 Million	--
2013-12-31	0.00%	$0.00	$34.84 Million	--
2012-12-31	0.00%	$0.00	$34.67 Million	--
2011-12-31	0.00%	$0.00	$19.81 Million	--
2009-12-31	21.80%	$10.00 Million	$45.87 Million	+4.25pp
2008-12-31	17.55%	$9.99 Million	$56.95 Million	+8.12pp
2007-12-31	9.43%	$4.20 Million	$44.54 Million	-12.33pp
2006-12-31	21.76%	$15.88 Million	$72.95 Million	-5.63pp
2005-12-31	27.39%	$28.53 Million	$104.15 Million	-25.92pp
2004-12-31	53.32%	$70.94 Million	$133.06 Million	+30.28pp
2003-12-31	23.03%	$32.27 Million	$140.08 Million	-5.70pp
2002-12-31	28.74%	$25.60 Million	$89.06 Million	+26.40pp
2000-12-31	2.34%	$3.00 Million	$127.97 Million	--

pp = percentage points

About Agenus Inc

NASDAQ:AGEN USA Biotechnology

Market Cap

$138.78 Million

Market Cap Rank

#18745 Global

#4142 in USA

Share Price

$3.84

Change (1 day)

-1.79%

52-Week Range

$2.77 - $7.06

All Time High

$144.45